Edition:
United States

Ranbaxy Laboratories Ltd (RANB.NS)

RANB.NS on National Stock Exchange of India

859.80INR
1 Apr 2015
Change (% chg)

-- (--)
Prev Close
Rs859.80
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
Rs869.70
52-wk Low
Rs790.10

Chart for

About

Ranbaxy Laboratories Limited (Ranbaxy) is a research-based international pharmaceutical company serving customers in over 150 countries. The Company develops, manufactures and markets generic, branded generic, value-added and over-the-counter (OTC) products, anti-retrovirals (ARVs), active pharmaceutical ingredients (APIs) and... (more)

Overall

Beta: --
Market Cap(Mil.): Rs355,822.31
Shares Outstanding(Mil.): 425.66
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.71 16.52
EPS (TTM): -- -- --
ROI: -- 14.89 11.32
ROE: -- 16.15 15.18

Ranbaxy beats class certification bid in pay-for-delay case

A federal judge has declined to certify a class of drug wholesalers who accuse generic drugmaker Ranbaxy Laboratories of illegally accepting payments from Cephalon Inc to delay the release of a generic version of the wakefulness drug Provigil.

Aug 29 2017

Ranbaxy settles 'pay-for-delay' case ahead of jury deliberations

Generic drugmaker Ranbaxy Laboratories has agreed to settle lawsuits accusing it of accepting payments from pharmaceutical company Cephalon Inc to delay the release of a generic version of the latter's wakefulness drug Provigil.

Jul 06 2017

Earnings vs. Estimates